Navigation Links
MINRAD International, Inc. Announces Reduction in Workforce
Date:11/20/2008

ORCHARD PARK, N.Y., Nov. 20 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (Amex: BUF), announced effective today it will reduce its workforce by approximately 35% or 50 positions.

Dave DiGiacinto, President and Chief Operating Officer, said, "We have taken this difficult, but necessary action to reduce our cost structure to conserve our cash in response to our current adverse financial condition as we discussed in our recently announced third quarter 2008 financial results on November 14, 2008. We appreciate the dedication and past efforts of those employees affected by today's announcement and thank them for their contributions."

This reduction in workforce will affect positions in company locations including Pennsylvania, New York and other geographies.

    Contact:  Charles R. Trego, Jr., Executive Vice President & Chief
              Financial Officer
              ctrego@minrad.com
              (716) 855-1068
              www.minrad.com

About the Company

The Company is an interventional pain management company with three focus areas: (1) anesthesia and analgesia, (2) real-time image guidance, and (3) conscious sedation. The Company's products are sold throughout the world. The anesthesia and analgesia business currently manufactures and sells generic inhalation anesthetics that are used for human and veterinary surgical procedures. The Company manufactures patented real-time image guidance technologies that facilitate minimally invasive surgery. The SabreSource(TM) system and the accompanying Light Sabre(TM) disposable products have broad applications in orthopedics, neurosurgery, interventional radiology and anesthesia. They enable improved accuracy and reduced radiation in interventional procedures and supp
'/>"/>

SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
2. MINRAD International, Inc. Announces $40.0 Million Private Placement
3. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
4. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
5. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
6. Cryo-Cell International, Inc. Reports Third Quarter 2008 Results
7. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
8. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
9. China Yingxia International, Inc. Appoints New Vice President of Finance
10. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
11. Sangui BioTech International, Inc. Files Remaining Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Selexis SA, a serial ... Cell Banks (RCBs) used for drug discovery to commercial ... will include Next-Generation Sequencing (NGS) data packages. ... biologic manufacturing by ensuring the integrity of the gene, ...
(Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... 2014 “Preparative & Process Chromatography ... Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, ... - Forecasts to 2019” provides a detailed overview ... market trends, and strategies impacting the preparative and ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Even with layoff announcements from more than a dozen employers in health ... in the past month it seemed like no one was searching for ... ... Strong growth continues in the health care field, with an average of ...
... PHILADELPHIA, Oct. 30 AVAX Technologies, Inc.,(OTC Bulletin ... October,24, 2008, it closed a bridge loan financing ... as amended by the Amendment to Convertible,Note and ... Agreement, the Company sold convertible promissory notes,(the "Notes") ...
... N.J., Oct. 30 Medarex, Inc.,(Nasdaq: MEDX ) announced ... Medarex,s net loss for the quarter ended September 30, ... a net loss of $51.6 million,or ($0.41) per share, for ... a non-cash charge of $5.4 million, or ($0.04) per share, ...
Cached Biology Technology:The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health 3AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing 2Medarex Announces 2008 Third Quarter Financial Results 2Medarex Announces 2008 Third Quarter Financial Results 3Medarex Announces 2008 Third Quarter Financial Results 4Medarex Announces 2008 Third Quarter Financial Results 5Medarex Announces 2008 Third Quarter Financial Results 6Medarex Announces 2008 Third Quarter Financial Results 7Medarex Announces 2008 Third Quarter Financial Results 8Medarex Announces 2008 Third Quarter Financial Results 9
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
(Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation is fundamentally ... evident than at international borders. Over the past decade, ... veteran travelers to self process through border control via ... increasing number of airports, seaports, and land borders across ...
(Date:12/11/2014)... Research and Markets , ... announced the addition of the "Biometrics Market in ... One major trend emerging in this market ... it is important to upgrade biometric solutions to the ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... over, oil, gasoline, and coal. Researchers are describing key ... energy-hungry world in the 21st Century in the eighth ... Challenges/Chemistry Solutions series. Those fuels include "green gasoline," "designer ... can help power an energy-hungry world into the future. ...
... been a focal point of recent climate change research because ... the larger Antarctic ice sheet. Yet while the southern Greenland ... how much this is contributing to rising sea levels, and ... was defined at a recent workshop organised by the European ...
... N.J. and Jamaica Plain, Mass., November 3, 2008 ... Biologic Laboratories (MBL) of the University of Massachusetts ... 2 trial of an anti- C. difficile ... difficile Associated Diarrhea (CDAD) successfully met its ...
Cached Biology News:Fuels of the future may come from 'ice that burns,' water and sunshine 2What is really happening to the Greenland icecap? 2Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea 2Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea 3
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
Biology Products: